Treatment of gestational trophoblastic tumors.

被引：37
作者：
Lurain J.R. [1 ]
机构：
[1] John I. Brewer Trophoblastic Disease Center, Department of Obstetrics and Gynecology, Northwestern University Medical School, Prentice Women's Hospital, 333 East Superior Street, Chicago, 60611, IL
来源：
Current Treatment Options in Oncology | 2002年 / 3卷 / 2期
关键词：
Gestational Trophoblastic Disease; Trophoblastic Tumor; Gestational Trophoblastic Tumor; Charing Cross Hospital; Nonmetastatic Disease;
D O I：
10.1007/s11864-002-0057-5
中图分类号：
学科分类号：
摘要：
Gestational trophoblastic tumors (invasive mole, choriocarcinoma, and placental site trophoblastic tumor) should be classified according to the National Cancer Institute (NCI), World Health Organization (WHO), and International Federation of Gynecology and Obstetrics (FIGO) criteria into nonmetastatic, low-risk metastatic, and high-risk metastatic categories. Nonmetastatic tumors (FIGO Stage I) can be treated with a variety of single-agent methotrexate or actinomycin D protocols, resulting in cure of essentially all patients. Metastatic low-risk tumors (FIGO Stages II and III, WHO score < 8) should be treated with 5-day dosage schedules of methotrexate or actinomycin D, with cure rates approaching 100%. Metastatic high-risk tumors (FIGO Stage IV, WHO score > 7) require combination chemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO) with or without adjuvant radiation therapy and surgery to achieve cure rates of 80% to 90%.
引用
收藏
页码：113 / 124
页数：11
相关论文
共 93 条
[1]  
Lurain JR(1991)Prognostic factors in gestational trophoblastic tumors. Am J Obstet Gynecol 64 611-616
[2]  
Casanova LA(1994)Evaluation of prognostic factors and staging in gestational trophoblastic tumors. Obstet Gynecol 84 969-973
[3]  
Miller DS(1995)Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 172 574-579
[4]  
Soper JT(1986)Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 23 111-118
[5]  
Evans AC(1989)The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours. Br J Obstet Gynecol 96 795-802
[6]  
Conway MR(1985)Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 152 59-62
[7]  
Lurain JR(1988)Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 72 413-418
[8]  
Elfstrand EP(1996)A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 60 292-294
[9]  
Berkowitz RS(1990)Metastatic infusion with folinic acid in primary therapy of nonmetastatic gestational trophoblastic tumors. Gynecol Oncol 36 56-59
[10]  
Goldstein DP(1994)High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 54 282-287
12345678910